DEL-DESIRAN Trademark

Trademark Overview


On Friday, April 5, 2024, a trademark application was filed for DEL-DESIRAN with the United States Patent and Trademark Office. The USPTO has given the DEL-DESIRAN trademark a serial number of 98486061. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, October 30, 2024. This trademark is owned by Avidity Biosciences, Inc.. The DEL-DESIRAN trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Oligonucleotide-conjugate based therapies, oligonucleotide-antibody conjugate based therapies, and oligonucleotide-antibody fragment conjugate based therapies for the treatment of metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, oncological, hepatological, ophthalmic, respiratory, central and/or peripheral neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

Providing medical and scientific research information in the fields of pharmaceuticals and biotechnology
del-desiran

General Information


Serial Number98486061
Word MarkDEL-DESIRAN
Filing DateFriday, April 5, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateWednesday, October 30, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesOligonucleotide-conjugate based therapies, oligonucleotide-antibody conjugate based therapies, and oligonucleotide-antibody fragment conjugate based therapies for the treatment of metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, oncological, hepatological, ophthalmic, respiratory, central and/or peripheral neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
Goods and ServicesProviding medical and scientific research information in the fields of pharmaceuticals and biotechnology

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 5, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, April 5, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAvidity Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events


Event DateEvent Description
Friday, April 5, 2024NEW APPLICATION ENTERED
Thursday, September 12, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 18, 2024ASSIGNED TO EXAMINER
Wednesday, October 30, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, October 30, 2024NON-FINAL ACTION WRITTEN
Wednesday, October 30, 2024NON-FINAL ACTION E-MAILED